Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J. Travagli, B. Caillou, M. Ricard, J. Lumbroso, F. Vathaire, M. Schlumberger (2006)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.The Journal of clinical endocrinology and metabolism, 91 8
MG Ghi, A Paccagnella, D Ferrari (2013)
For the GSTTC Italian Study Group. A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluroruracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826)J Clin Oncol, 31
M. Ghi, A. Paccagnella, R. Orecchia, S. Parisi, F. Bertoni, N. Minguzzi, V. Baggio, M. Polsinelli, F. Bunkheila, M. Palazzi (2013)
A Phase 2-3 Study Comparing Concomitant Chemoradiation Therapy (CRT) Versus Cetuximab/RT (CET/RT) With or Without Induction Docetaxel/Cisplatin/5-Fluorouracil (TPF) in Locally-Advanced Head and Neck Squamous Cell Carcinoma (LASCCHN) – Efficacy Results of the GSTTC Italian Study (NCT01086826)International Journal of Radiation Oncology Biology Physics, 87
G. Pellegriti, F. Frasca, C. Regalbuto, S. Squatrito, R. Vigneri (2013)
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk FactorsJournal of Cancer Epidemiology, 2013
N. Agrawal, M. Frederick, C. Pickering, C. Bettegowda, K. Chang, Ryan Li, C. Fakhry, T. Xie, Jiexin Zhang, Jing Wang, Nianxiang Zhang, A. El-Naggar, S. Jasser, J. Weinstein, L. Treviño, J. Drummond, D. Muzny, Yuanqing Wu, L. Wood, R. Hruban, W. Westra, W. Koch, J. Califano, R. Gibbs, D. Sidransky, B. Vogelstein, V. Velculescu, N. Papadopoulos, D. Wheeler, K. Kinzler, J. Myers (2011)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1Science, 333
Nicolas Stransky, A. Egloff, Aaron Tward, Aleksandar Kostic, K. Cibulskis, A. Sivachenko, G. Kryukov, M. Lawrence, C. Sougnez, A. McKenna, Erica Shefler, A. Ramos, P. Stojanov, S. Carter, Douglas Voet, M. Cortés, Daniel Auclair, Michael Berger, G. Saksena, C. Guiducci, R. Onofrio, Melissa Parkin, M. Romkes, J. Weissfeld, Raja Seethala, Lin Wang, C. Rangel-Escareño, J. Fernández-López, A. Hidalgo-Miranda, J. Meléndez-Zajgla, W. Winckler, K. Ardlie, S. Gabriel, M. Meyerson, Eric Lander, G. Getz, Todd Golub, Levi Garraway, J. Grandis (2011)
The Mutational Landscape of Head and Neck Squamous Cell CarcinomaScience, 333
J. Lefebvre, Y. Pointreau, F. Rolland, M. Alfonsi, A. Baudoux, C. Sire, D. Raucourt, O. Malard, M. Degardin, C. Tuchais, E. Blot, M. Rives, E. Reyt, J. Tourani, L. Geoffrois, F. Peyrade, F. Guichard, D. Chevalier, E. Babin, P. Lang, F. Janot, G. Calais, P. Garaud, É. Bardet (2013)
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 7
Mingzhao Xing (2013)
Molecular pathogenesis and mechanisms of thyroid cancerNature Reviews Cancer, 13
M. Keck, Zhixiang Zuo, A. Khattri, Christopher Brown, T. Stricker, R. Weichselbaum, M. Lingen, E. Cohen, K. White, E. Vokes, P. Hammerman, T. Seiwert (2013)
Genomic profiling of kinase genes in head and neck squamous cell carcinomas to identify potentially targetable genetic aberrations in FGFR1/2, DDR2, EPHA2, and PIK3CA.Journal of Clinical Oncology, 31
L. Carr, D. Mankoff, B. Goulart, K. Eaton, P. Capell, E. Kell, J. Bauman, Renato Martins (2010)
Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging CorrelationClinical Cancer Research, 16
C. Chung, J. Parker, G. Karaca, Junyuan Wu, W. Funkhouser, D. Moore, D. Butterfoss, Dong Xiang, A. Zanation, Xiaoying Yin, W. Shockley, M. Weissler, L. Dressler, C. Shores, W. Yarbrough, C. Perou (2004)
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expressionCancer Cell, 5
R. Haddad, A. O'neill, G. Rabinowits, R. Tishler, F. Khuri, D. Adkins, Joseph Clark, N. Sarlis, J. Lorch, J. Beitler, S. Limaye, S. Riley, M. Posner (2013)
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.The Lancet. Oncology, 14 3
E. Cohen, T. Karrison, M. Kocherginsky, C. Huang, M. Agulnik, B. Mittal, F. Yunus, S. Samant, B. Brockstein, L. Raez, R. Mehra, Priya Kumar, F. Ondrey, T. Seiwert, V. Villaflor, D. Haraf, E. Vokes (2012)
DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN).Journal of Clinical Oncology, 30
B. Escudier (2011)
Sorafenib for the management of advanced renal cell carcinomaExpert Review of Anticancer Therapy, 11
Selena Liao, M. Shindo (2012)
Management of well-differentiated thyroid cancer.Otolaryngologic clinics of North America, 45 5
C. Nutting, B. Jarzab, R. Elisei, S. Siena, L. Bastholt, C. Fouchardière, F. Pacini, R. Paschke, Y. Shong, S. Sherman, J. Smit, J. Chung, H. Siedentop, I. Molnár, M. Schlumberger (2013)
Sorafenib in locally advanced or metastatic patients with radioactive iodine-refractory differentiated thyroid cancer: The phase III DECISION trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 18_suppl
M. Ghi, A. Paccagnella, D. Ferrari, P. Foa, M. Rocca, E. Verri, E. Maiello, G. Azzarello, C. D'Ambrosio, C. Casanova, M. Guaraldi, G. Mantovani, C. Rossetto, A. Bonetti, T. Cipani, L. Crinò, H. Koussis, G. Pieri, A. Gava, I. Floriani (2013)
A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826).Journal of Clinical Oncology, 31
R. Kloos, M. Ringel, M. Knopp, N. Hall, M. King, R. Stevens, Jiachao Liang, P. Wakely, V. Vasko, M. Saji, J. Rittenberry, Lai Wei, D. Arbogast, Minden Collamore, J. Wright, M. Grever, M. Shah (2009)
Phase II trial of sorafenib in metastatic thyroid cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 10
D. Hayes, J. Grandis, A. El-Naggar (2013)
The Cancer Genome Atlas: Integrated analysis of genome alterations in squamous cell carcinoma of the head and neck.Journal of Clinical Oncology, 31
E. Cohen, L. Rosen, E. Vokes, M. Kies, A. Forastiere, F. Worden, M. Kane, E. Sherman, S. Kim, P. Bycott, M. Tortorici, D. Shalinsky, Katherine Liau, R. Cohen (2008)
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 29
J. Bonner, P. Harari, J. Giralt, N. Azarnia, D. Shin, R. Cohen, Christopher Jones, R. Sur, D. Raben, J. Jassem, R. Ove, M. Kies, J. Baselga, H. Youssoufian, N. Amellal, E. Rowinsky, E. Rowinsky, K. Ang (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.The New England journal of medicine, 354 6
Within the Head and Neck Cancer-Track at the American Society of Clinical Oncology (ASCO) Annual Meeting 2013 a large number of abstracts have been presented. The aim of this short review is to highlight those abstracts with the highest immediate clinical impact and to draw attention to some of the latest basic research findings, which might open new pathways toward more efficacious treatments.
memo - Magazine of European Medical Oncology – Springer Journals
Published: Sep 21, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.